ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Diisopropylethylamine → HCID 86685777、化合物

HRID 74822
ノート
印刷プレビュー

反応式

HRID 74822 の反応式
[O:1]=[C:2]1[CH:6]=[CH:5][C:4](=[O:7])[N:3]1[CH2:8][CH2:9][CH2:10][CH2:11][C:12]([OH:14])=O.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C.FC(F)(F)C(O)=O.[CH3:55][NH:56][C:57]([CH3:105])([C:59]([NH:61][C@H:62]([C:66]([N:68]([C@@H:70]([C@@H:101]([CH3:104])[CH2:102][CH3:103])[C@H:71]([O:99][CH3:100])[CH2:72][C:73]([N:75]1[CH2:79][CH2:78][CH2:77][C@H:76]1[C@H:80]([O:97][CH3:98])[C@@H:81]([CH3:96])[C:82]([NH:84][C@H:85]([C:93]([OH:95])=[O:94])[CH2:86][C:87]1[CH:92]=[CH:91][CH:90]=[CH:89][CH:88]=1)=[O:83])=[O:74])[CH3:69])=[O:67])[CH:63]([CH3:65])[CH3:64])=[O:60])[CH3:58]>ClCCl.CS(C)=O.CN(C=O)C>[O:7]=[C:4]1[CH:5]=[CH:6][C:2](=[O:1])[N:3]1[CH2:8][CH2:9][CH2:10][CH2:11][C:12]([N:56]([CH3:55])[C:57]([CH3:105])([C:59]([NH:61][C@H:62]([C:66]([N:68]([C@@H:70]([C@@H:101]([CH3:104])[CH2:102][CH3:103])[C@H:71]([O:99][CH3:100])[CH2:72][C:73]([N:75]1[CH2:79][CH2:78][CH2:77][C@H:76]1[C@H:80]([O:97][CH3:98])[C@@H:81]([CH3:96])[C:82]([NH:84][C@H:85]([C:93]([OH:95])=[O:94])[CH2:86][C:87]1[CH:92]=[CH:91][CH:90]=[CH:89][CH:88]=1)=[O:83])=[O:74])[CH3:69])=[O:67])[CH:63]([CH3:64])[CH3:65])=[O:60])[CH3:58])=[O:14]
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 4

HCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 232738725-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanoic acidHCID 86685778N,2-dimethylalanyl-N-{(1S,2R)-4-{(2S)-2-[(1R,2R)-3-{[(1S)-1-carboxy-2-phenylethyl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl}-N-methyl-L-valinamide-trifluoroacetic acid salt

生成物 1

HCID 86685777HCID 86685777、化合物収率 3.3%

試薬・触媒・溶媒 3

HCID 679Dimethyl Sulfoxide溶媒HCID 6228Dimethylformamide溶媒2 回HCID 6344Dichloromethane溶媒2 回

実験手順

To a stirring solution of 5-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)pentanoic acid (12 mg, 0.061 mM) in 0.4 mL of dichloromethane, and 0.1 mL of DMF, HATU (23.2 mg, 0.061 mM) was added followed by Hunig's base (0.033 mL, 0.188 mM). The reaction was allowed to stir for 5 minutes before #115 (39 mg, 0.047 mM) was added as a solution in 0.4 mL of dichloromethane, and 0.1 mL of DMF. The reaction was allowed to stir at room temperature for 3 hours and 15 minutes before being quenched through the addition of water containing a small amount of TFA. Reaction was then reduced down. Crude material was dissolved with DMSO and purified by reverse phase chromatography (Method J). The appropriate fractions were concentrated then (Genevac). Material was then further purified by reverse phase chromatography (Method K) with the appropriate fractions being concentrated (Genevac). Material was then transferred to a small vial using dichloromethane and methanol before being reduced down (Genevac) to afford mv#115 (1.4 mg, 3.3%) oil/solid mix. HPLC (Protocol A at 45° C.): m/z 897.5 [M+H+], retention time=9.149 minutes (purity >97%).

後処理

  1. custombefore being quenched through the addition of water containing a small amount of TFA
  2. customReaction
  3. custompurified by reverse phase chromatography (Method J)
  4. concentrationThe appropriate fractions were concentrated
  5. customMaterial was then further purified by reverse phase chromatography (Method K) with the appropriate fractions
  6. concentrationbeing concentrated (Genevac)

出典と根拠

ORDレコード
ord-4816497456ca46f9a2fe9bd4f1a522b9
出典データセット
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08828401B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート